Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD
- PMID: 35293152
- PMCID: PMC9234625
- DOI: 10.1002/hep4.1932
Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD
Abstract
Genetic predisposition and unhealthy lifestyle are risk factors for nonalcoholic fatty liver disease (NAFLD). We investigated whether the genetic risk of NAFLD is modified by physical activity, muscular fitness, and/or adiposity. In up to 242,524 UK Biobank participants without excessive alcohol intake or known liver disease, we examined cross-sectional interactions and joint associations of physical activity, muscular fitness, body mass index (BMI), and a genetic risk score (GRS) with alanine aminotransferase (ALT) levels and the proxy definition for suspected NAFLD of ALT levels > 30 U/L in women and >40 U/L in men. Genetic predisposition to NAFLD was quantified using a GRS consisting of 68 loci known to be associated with chronically elevated ALT. Physical activity was assessed using accelerometry, and muscular fitness was estimated by measuring handgrip strength. We found that increased physical activity and grip strength modestly attenuate genetic predisposition to elevation in ALT levels, whereas higher BMI markedly amplifies it (all p values < 0.001). Among those with normal weight and high level of physical activity, the odds of suspected NAFLD were 1.6-fold higher in those with high versus low genetic risk (reference group). In those with high genetic risk, the odds of suspected NAFLD were 12-fold higher in obese participants with low physical activity versus those with normal weight and high physical activity (odds ratio for NAFLD = 19.2 and 1.6, respectively, vs. reference group). Conclusion: In individuals with high genetic predisposition for NAFLD, maintaining a normal body weight and increased physical activity may reduce the risk of NAFLD.
© 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Conflict of interest statement
E.A.A. reports advisory board fees from Apple, DeepCell, AstraZeneca and Personalis, outside the submitted work. The other authors have nothing to report.
Figures
Similar articles
-
Physical frailty, genetic predisposition, and the risks of severe non-alcoholic fatty liver disease and cirrhosis: a cohort study.J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1491-1500. doi: 10.1002/jcsm.13506. Epub 2024 Jun 18. J Cachexia Sarcopenia Muscle. 2024. PMID: 38887910 Free PMC article.
-
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.BMC Pediatr. 2020 Mar 14;20(1):121. doi: 10.1186/s12887-020-02022-y. BMC Pediatr. 2020. PMID: 32171275 Free PMC article.
-
Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.Clin Nutr. 2018 Oct;37(5):1550-1557. doi: 10.1016/j.clnu.2017.08.018. Epub 2017 Aug 30. Clin Nutr. 2018. PMID: 28918170
-
A review of non-alcoholic fatty liver disease in non-obese and lean individuals.J Gastroenterol Hepatol. 2021 Jun;36(6):1497-1507. doi: 10.1111/jgh.15353. Epub 2020 Dec 15. J Gastroenterol Hepatol. 2021. PMID: 33217052 Review.
-
Nonobese Fatty Liver Disease.Clin Gastroenterol Hepatol. 2017 Apr;15(4):474-485. doi: 10.1016/j.cgh.2016.08.028. Epub 2016 Aug 28. Clin Gastroenterol Hepatol. 2017. PMID: 27581063 Review.
Cited by
-
Sweating it out: How physical activity can combat high genetic risk for nonalcoholic fatty liver disease.Liver Int. 2023 Aug;43(8):1623-1625. doi: 10.1111/liv.15642. Liver Int. 2023. PMID: 37452506 Free PMC article. No abstract available.
-
A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes.medRxiv [Preprint]. 2024 Feb 4:2024.02.03.24302258. doi: 10.1101/2024.02.03.24302258. medRxiv. 2024. Update in: Hepatology. 2024 Aug 27. doi: 10.1097/HEP.0000000000001066 PMID: 38352379 Free PMC article. Updated. Preprint.
-
Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population.Diabetes Metab Syndr Obes. 2024 Jan 8;17:143-155. doi: 10.2147/DMSO.S438652. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38222035 Free PMC article.
-
The interaction of genetics and physical activity in the pathogenesis of metabolic dysfunction associated liver disease.Sci Rep. 2024 Aug 1;14(1):17817. doi: 10.1038/s41598-024-68271-4. Sci Rep. 2024. PMID: 39090170 Free PMC article.
-
Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.Med Sci Sports Exerc. 2023 Sep 1;55(9):1717-1726. doi: 10.1249/MSS.0000000000003199. Med Sci Sports Exerc. 2023. PMID: 37126039 Free PMC article.
References
-
- Brunt EM, Wong V‐S, Nobili V, Day CP, Sookoian S, Maher JJ, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080. - PubMed
-
- Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta‐analysis. J Hepatol. 2019;71:793–801. - PubMed
-
- Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up. Hepatology. 2015;61:1547–54. - PubMed
-
- Sookoian S, Pirola CJ. Non‐alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol. 2008;49:600–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical